Close it

Would you like to become a TBEC member? Please fill out the form below.

By becoming a TBEC member, you agree to endorse the values and the principles of the TB Europe Coalition, and agree with its membership rights and responsibilities.

Membership is free of charge.

TBEC membership rights

TBEC membership responsibilities











Press Release
Our future depends on humanity and good deeds

Our future depends on humanity and good deeds

A report from one of our members, the NGO ‘Towards a Future without Tuberculosis’ As in all democracies, people and their problems – both on a personal and societal level – constitute one of the main elements of a society. However, people suffering from diseases consider themselves outcasts from the rest of humanity during the course of their illness.  During the course of my work, I was able to meet with a variety of patients and learn about their medical and social problems. As a former patient myself, the idea came to me to create an NGO that would work to solve patients’ problems. The idea to create a non-governmental organisation (NGO) which would work on patients’ rights, globally and here in Azerbaijan, was always a priority. With guidance from TBEC and the support of TB-REP, as well as the invaluable advice of Elchin Mukhtarli, who answered all my questions, I established the NGO ‘Towards a Future Without Tuberculosis’, which protects patients across Azerbaijan when their rights are being undermined. I started to travel around the republic as a TB project coordinator and when meeting patients, I asked not only about the progression of their treatment but also about their More…

Open letter to Jamala to become a Goodwill Ambassador on Tuberculosis

Open letter to Jamala to become a Goodwill Ambassador on Tuberculosis

Dear Jamala, Admiring your work and achievements, organizations and activists are calling you to join our efforts to fight tuberculosis across the region of Eastern Europe and Central Asia. We used to think that tuberculosis is a disease of the past, but this is not the case. Tuberculosis is the world’s leading infectious killer, responsible for more deaths each year than HIV and malaria combined. Since 2000, 7.4 million people have fallen ill with tuberculosis in Europe and 944,000 died. In Ukraine alone more than 30,000 people are getting ill every year, with 4 people diagnosed as being sick every hour. Now we face tuberculosis, which has become even more severe than it has ever been before. New forms of the disease, called drug-resistant tuberculosis, are difficult to cure. The few available medicines to treat drug-resistant tuberculosis are very toxic. Treatment may take for up to 2 years and it is very painful for the patient. On average only half of all patients with resistant forms of tuberculosis in our region are cured. The other half of patients die. In most cases, tuberculosis is spread through the air when a sick person coughs. In fact, it is a major drug-resistant More…

Stop TB Partnership extends the deadline for the 2015 Kochon Prize until 24 July

Stop TB Partnership extends the deadline for the 2015 Kochon Prize until 24 July

Geneva, Switzerland – The Stop TB Partnership Secretariat has just announced that it will be extending the closing date of this year’s Kochon Prize call for nomination until Friday, 24 July, 2015. Funded by the Kochon Foundation, a non-profit foundation registered in the Republic of Korea, the USD 65,000 prize is awarded once a year to persons or organizations that have made a highly significant contribution to fighting TB. This year’s theme is “Unrecognized/unsung heroes working in TB”. Day by day, unknown and unrecognized heroes make miracles happen for those suffering because of TB. They are health workers, community workers, volunteers, researchers and service providers. These heroes battle restlessly with TB, and their efforts are making a huge impact in the lives of those affected by the disease — but they are rarely known or recognized for their huge efforts and impact. The nominations are open to individuals and organizations that are working in often challenging situations, with professionalism and dedication, making significant impact in changing and saving the lives of those affected by TB. Nominations should include: A form completed by the nominator, which can be found by clicking here. A letter of support from the nominator. All documentation should be More…

Press Release: Europe’s Leaders Approve Riga Declaration on TB and MDR-TB

Press Release: Europe’s Leaders Approve Riga Declaration on TB and MDR-TB

Riga, 31st March 2015 – At the conclusion of the first Eastern Partnership Ministerial Conference on Tuberculosis  (TB) and Its Multidrug-Resistance (MDR-TB), the Tuberculosis Europe Coalition (TBEC) applauds the approval of the Riga Declaration by Ministers of Health, Finance and Social Affairs from across European Union Member States and Eastern Partnership countries. TBEC would particularly like to congratulate the Latvian government for taking the initiative to organise this important meeting as part of their Presidency of the EU Council and the collaborative efforts of partners across Europe, including the World Health Organisation, ECDC, the European Commission, the Global Fund to Fight AIDS, TB and Malaria, the Stop TB Partnership and civil society. This meeting comes at a crucial time in the fight against TB and MDR-TB in Europe. The European region contends with the highest rates of multidrug-resistant TB (MDR-TB) worldwide. Fifteen of the twenty-seven high MDR-TB burden countries in the world are situated in the region and four of these (Latvia, Lithuania, Estonia and Bulgaria) are situated in the European Union. Currently, Europe is failing to tackle MDR-TB effectively. More than 50% of MDR-TB cases are not detected and less than half are cured. Without increased political and financial commitment, More…

Finding a Way to Defeat TB: GF Chief Underlines a Focus on ‘Hot Spots’ of Disease at the Barcelona Conference

Finding a Way to Defeat TB: GF Chief Underlines a Focus on ‘Hot Spots’ of Disease at the Barcelona Conference

TB, one of the oldest diseases known to mankind, killed more than 1.5 million people in 2013, even though it is entirely curable. Leaders, health experts and civil society activists meeting recently in Barcelona at the annual Union Conference on Lung Health called for an approach that aims to defeat the disease, by working with affected communities and focusing on vulnerable groups such as miners and prisoners.  “We have to concentrate on vulnerable groups and hot spots,” said Aaron Motsoaledi, Minister of Health for South Africa. “In South Africa we are targeting particular areas and not using a one-size-fits-all approach.” Miners in South Africa represent the highest TB rates in the world. Incidence of TB is 70 times higher among prisoners than in the general population. Incidence of TB is falling at an annual rate of 1.5 percent, far too slowly. “I don’t think TB has been prioritized to the extent that it needs to be,” said Amy Bloom, senior technical adviser at USAID. “In the United States we don’t see TB and we don’t hear about it. People ask me: is there still TB in the world?” Even in South Africa, deaths from mining accidents attract far more attention More…

LAUNCH OF THE 2014 GLOBAL TUBERCULOSIS REPORT: Is Tuberculosis becoming the world’s deadliest communicable disease?

LAUNCH OF THE 2014 GLOBAL TUBERCULOSIS REPORT: Is Tuberculosis becoming the world’s deadliest communicable disease?

RUSSIAN VERSION BELOW   Brussels, 22 October 2014 – The Tuberculosis Europe Coalition is deeply concerned by the increase in TB cases and deaths disclosed today by the 2014 Global TB Report and calls on the European Union to increase its political and financial commitment to fight this disease in Europe and worldwide. The new report by the World Health Organisation reveals that 9 million people developed TB and 1.5 million people died from the disease in 2013. This number represents an extremely concerning increase compared to the 2012 estimated 1.3 million deaths and suggests that TB may outstrip HIV in the sad race to becoming the world’s deadliest communicable disease. The death toll from TB continues to be unacceptably high, especially considering that TB is curable. 2015 is just around the corner but we are still far from reaching the Millennium Development Goals targets for TB, especially in Africa and Europe. Most worryingly, multi-drug resistant TB (MDR-TB), a man-made disease which is extremely difficult to treat and a testimony of our failure to invest in sustainable health systems, is also on the rise. Almost half a million people developed MDR-TB in 2013 and the European Region continues to bear More…

PRESS RELEASE: No time to lose for the EU: Drug-resistant TB is a regional threat

PRESS RELEASE: No time to lose for the EU: Drug-resistant TB is a regional threat

On World Tuberculosis Day 2014, the TB Europe Coalition calls on European Union institutions to recognise multidrug-resistant TB (MDR-TB) as a cross border health threat and to provide regional political leadership in the fight against MDR-TB in the European Region. “TB does not respect national boundaries. In a globalised world and an integrated EU, failure to respond to the upswing in drug resistance in the region will have grave repercussions,” said Claudiu Tănăsescu, Romanian Member of the European Parliament (MEP). TB is an ancient disease that continues to kill 1.3 million people every year. The spread of its drug-resistant forms, including some that are completely incurable, represents a serious threat to the control of the disease, especially in the European region. Last year alone, the World Health Organisation reported an estimated 74,000 cases of MDR-TB in the region, accounting for almost a quarter of all drug-resistant TB cases worldwide. MDR-TB does not respond to the standard TB treatment, which means it is much more costly and difficult to treat – in some cases, drug-resistant TB can cost 100 times more to treat than a normal case of TB. Many governments in the region often do not have the resources or More…

wink.pink